Keyphrases
Antibacterial Properties
20%
Asthma Exacerbation
20%
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
100%
Double-blind Placebo-controlled Trial
20%
Doxycycline
100%
Dropout
20%
Effective Management
20%
High Dropout Rate
40%
Limited Samples
20%
Medical Therapy
20%
Moderate Disease
20%
Nasal Polyp Score
40%
No Significant Difference
20%
Non-surgical Management
20%
Oral Corticosteroids
20%
Pathophysiology
20%
Patient Demographics
20%
Patient Management
20%
Patient Outcomes
20%
Placebo
20%
Placebo Groups
40%
Reasons for Dropout
20%
Severe Disease
20%
Sino-Nasal Outcome Test
20%
SNOT-22
20%
SNOT-22 Score
20%
Tertiary Level
20%
Treatment Group
20%
Visual Analog Scale
40%
Medicine and Dentistry
Anti-Inflammatory Drug
28%
Antibacterial Activity
14%
Arm
14%
Asthma Exacerbation
14%
Chronic Rhinosinusitis
100%
Combination Therapy
14%
Diseases
28%
Doxycycline
100%
Nasal Polyp
100%
Oral
14%
Pathophysiology
14%
Patient Population
14%
Placebo
57%
Treatment Group
14%
Visual Analog Scale
28%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
28%
Antiinfective Agent
14%
Asthma
14%
Chronic Rhinosinusitis
100%
Combination Therapy
14%
Diseases
28%
Doxycycline
100%
Nose Polyp
100%
Pathophysiology
14%
Placebo
57%
Treatment Group
14%